Roche Extends Deadline For Spark Acquisition As US, UK Regulators Seek Additional InformationBenzinga • 06/10/19
FDA approves Genentech's Polivy as part of first chemoimmunotherapy regimen for patients with diffuse large B-cell lymphomaMarket Watch • 06/10/19
Roche's $4.8 Billion Buyout Of Spark Delayed Amid Competitive WorriesInvestors Business Daily • 06/10/19
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster HeadacheZacks Investment Research • 06/07/19
This Biotech Has A 'Swing Factor' In SMA Drugs And It's Slugging BiogenInvestors Business Daily • 05/07/19
Roche Holding AG (RHHBY) CEO Severin Schwan on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/17/19
Roche's Latest Triple-Combination Data In Breast Cancer Lays Groundwork To Target Other Cancer IndicationsSeeking Alpha • 04/11/19
The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis EarningsBenzinga • 04/03/19